04:51 PM EDT, 05/24/2024 (MT Newswires) -- Recursion (RXRX) late Friday said Robert Hershberg was selected to be the next board chairman, succeeding Martin Chavez, who is stepping down at the end of his current term after more than four years.

Hershberg has been a Recursion board member since May 2020. He currently is board chairman and chief executive officer at vaccines company HilleVax ( HLVX ) and also a venture partner at Frazier Healthcare Partners.

Price: 9.18, Change: +0.02, Percent Change: +0.22